Skip to content

American Journal on Addictions

ISSN 1055-0496

4 papers in the library · 91 citations · publishing 1994-2018

Papers

Sort Most recent Most cited

Trends in DMT and other tryptamine use among young adults in the United States

American Journal on Addictions September 27, 2018 Joseph J Palamar, Austin Le 35 citations

Background and Objectives The popularity of tryptamines such as N,N ‐dimethyltryptamine (DMT) appears to be increasing in the United States (US), but epidemiologic literature on prevalence of use is scant. This paper aims to determine trends in prevalence and correlates of past‐year tryptamine use among a nationally representative sample of young adults in the US. Methods Participants in the...

Intensive ketamine use for multiple years: A case report

American Journal on Addictions October 1, 2014 James X. Liu, Erin Zerbo, Stephen Ross 1 citation

Ketamine is known within the medical field for its anesthetic properties, yet its unique psychedelic and antidepressant properties are being increasingly recognized. We document the case of a patient with bipolar I disorder and an extensive history of substance dependence who used large doses of ketamine (1–3 g) on a daily basis over a period of 5 years, and described acute antidepressant...

Hallucinogen Use Disorders Among Adult Users of MDMA and Other Hallucinogens

American Journal on Addictions September 3, 2008 Li-Tzy Wu, Christopher L. Ringwalt, Paolo Mannelli et al. 30 citations

We investigated the prevalence, patterns, and correlates of past‐year DSM‐IV hallucinogen use disorders (HUDs) among past‐year users of MDMA and other hallucinogens from a sample of Americans 18 or older (n = 37,227). Users were categorized as MDMA users and other hallucinogen users. Overall, one in five (20%) MDMA users and about one in six (16%) other hallucinogen users reported at least one...

Cannabis Psychotic Disorder

American Journal on Addictions 1994 Amanda J. Gruber, Harrison G. Pope 25 citations

Although “cannabis‐induced delusional disorder” is recognized in DSM‐III‐R and appears as “cannabis psychotic disorder” in the draft criteria for DSM‐IV, little information on this entity is available. The authors reviewed available studies of psychiatric syndromes attributed to cannabis use and then surveyed 9,432 admissions at two psychiatric centers, seeking cases of cannabis‐induced...